SFX by Ex Libris Inc.

Title:	An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency
Source:	Science [0036-8075] Ferrari, G yr:1991

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	TOLSTOSHEV, P. "GENE-THERAPY, CONCEPTS, CURRENT TRIALS AND FUTURE-DIRECTIONS." Annual review of pharmacology and toxicology 33.1 (1993): 573-596.
description	2.	Leiden, J M M. "Gene therapy--promise, pitfalls, and prognosis." The New England journal of medicine 333.13 (1995): 871-3.
description	3.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	4.	Cavazzana-Calvo, M. "Gene therapy for severe combined immunodeficiency: are we there yet?" The journal of clinical investigation 117.6 (2007): 1456-65.
description	5.	Basil, H. "Applications of gene therapy to kidney disease." Current opinion in nephrology and hypertension 12.4 (2003): 439-445.
description	6.	Hacein-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1." Science 302.5644 (2003): 415-9.
description	7.	Hacein-Bey-Abina, S. "A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency." New England Journal of Medicine, The 348.3 (2002): 255-6.
description	8.	Cavazzana-Calvo, M. "Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1." The journal of clinical investigation 118.9 (2008): 3132-42.
description	9.	Hacein-Bey-Abina, S. "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy." New England Journal of Medicine, The 346.16 (2002): 1185-1193.
description	10.	Fischer, A. "Severe combined immunodeficiency. A model disease for molecular immunology and therapy." Immunological reviews 203.1 (2005): 98-109.
description	11.	Liu, Margaret A A. "Vaccine delivery methods using viral vectors." Molecular pharmaceutics 4.1 (2007): 18-32.
description	12.	Buckley, R H H. "Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency." The New England journal of medicine 340.7: 508-16.
description	13.	Cavazzana-Calvo, M. "Gene therapy for severe combined immunodeficiency." Annual review of medicine 56.1 (2005): 585-602.
description	14.	Gaspar, A J B. "Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency." Gene therapy 10.24 (2003): 1999-2004.
description	15.	Azzazy, Hassan M.E M. "Gene doping : Of mice and men." Clinical biochemistry 42.6 (2009): 435-441.
description	16.	Berger, Abi. "Safety ruling opens gene therapy to women with CF." New Scientist (1995): 8-8.
description	17.	Hakimi, P. "Over-expression of the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) in skeletal muscle repatterns energy metabolism in the mouse." The Journal of biological chemistry 282.45 (2007): 32844-55.
description	18.	Shepherd, Richard J. "Public concerns in the United Kingdom about general and specific applications of genetic engineering: risk, benefit, and ethics." Science, technology & human values 22.1 (1997): 98-124.
description	19.	Edelstein, Michael L L. "Gene therapy clinical trials worldwide to 2007--an update." The journal of gene medicine 9.10 (2007): 833-42.
description	20.	FRIEDMAN., T. "GENE THERAPY FOR HUMAN GENETIC DISEASE." Science 175.4025 (1972): 949-55.